What is it about?
Anxiety, nausea and vomiting are commonly experienced by paediatric patients receiving chemotherapy. Our study aims to assess the feasibility and acceptability of IVR for preventing and managing anxiety, nausea and vomiting among paediatric cancer patients receiving their first chemotherapy.
Featured Image
Photo by Jessica Lewis on Unsplash
Why is it important?
Our findings suggest that immersive virtual reality (IVR) is feasible for improving anxiety and distress symptoms including nausea and vomiting among this vulnerable group.
Perspectives
It is hoped that this article will draw readers' greater attention to symptoms of anxiety and distress in childhood cancer chemotherapy patients and provide insights into the use of IVR.
Cho Lee Wong
The Chinese University of Hong Kong
Read the Original
This page is a summary of: Effects of immersive virtual reality for preventing and managing anxiety, nausea and vomiting among paediatric cancer patients receiving their first chemotherapy: A study protocol for an exploratory trial, PLoS ONE, October 2021, PLOS,
DOI: 10.1371/journal.pone.0258514.
You can read the full text:
Contributors
The following have contributed to this page
